KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Assets (2016 - 2025)

Globus Medical (GMED) has disclosed Current Assets for 15 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 2.37% year-over-year to $2.1 billion, compared with a TTM value of $2.1 billion through Dec 2025, down 2.37%, and an annual FY2025 reading of $2.1 billion, down 2.37% over the prior year.
  • Current Assets was $2.1 billion for Q4 2025 at Globus Medical, up from $1.9 billion in the prior quarter.
  • Across five years, Current Assets topped out at $2.2 billion in Q4 2024 and bottomed at $814.4 million in Q1 2021.
  • Average Current Assets over 5 years is $1.4 billion, with a median of $1.5 billion recorded in 2023.
  • The sharpest move saw Current Assets surged 108.41% in 2023, then dropped 10.08% in 2025.
  • Year by year, Current Assets stood at $864.5 million in 2021, then increased by 13.75% to $983.3 million in 2022, then surged by 94.78% to $1.9 billion in 2023, then rose by 13.67% to $2.2 billion in 2024, then decreased by 2.37% to $2.1 billion in 2025.
  • Business Quant data shows Current Assets for GMED at $2.1 billion in Q4 2025, $1.9 billion in Q3 2025, and $1.7 billion in Q2 2025.